Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Group 1 Standard of Care
Pacira Ireland Limited
Retraction of Colostomy
1 trial -
Group A (the standard 2HRZE/4HR regimenοΌ
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Tuberculosis TB in Sputum: (+) Microscopy
1 trial -
Iohexol 300 mg I/ml solution for injection, MORPHINE (CHLORHYDRATE) RENAUDIN 1 mg/ml, solution injectable
Tour Hekla
Evaluation of the CKD-Epi score to identify a glomerular filtration threshold predictive of morphine failure at usual dosage, using a reference method for assessing renal function: iohexol clearance. All other aspects of the protocol are part of standard care practice.
1 trial -
Rucacuzumab plus standard therapy
The First People's Hospital of Lianyungang
Acute Ischemic Stroke AIS
1 trial -
Standard BP control
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Standard clinical care first, followed by standard clinical care and varenicline
BRIGHT MINDS BIOSCIENCES INC.
Cannabis Dependence
1 trial -
Standard of care plus Epoprostenol infusion for 8 hours (hrs) per day up to 5 days maximum
United Therapeutics Europe Ltd
Frostbite
1 trial -
early standardised rhythm control
Rhythm Pharmaceuticals Netherlands B.V.
Atrial Fibrillation
1 trial -
Control (Standard treatment)
Grace Therapeutics
Moisture Associated Skin Damage
1 trial -
Diagnostic Test: standard-of-care imaging (68Ga-PSMA PET/CT), 68Ga-XACP3 PET/CT
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Rehabilitation Therapy as part of Standard of Care (Control)
BRIGHT MINDS BIOSCIENCES INC.
Acute Stroke
1 trial -
Standard Care Arm
United Therapeutics Europe Ltd
Radiation Proctopathy
1 trial -
Standard Dose Spirulina Platensis
Hospital Authority, Hong Kong
HBV Carrier
1 trial -
Standard OGTT
Vertex Pharmaceuticals (Australia) Pty.
Cystic Fibrosis
1 trial -
Standard clinical treatment
The First People's Hospital of Lianyungang
Acute Pancreatitis
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
TNK plus standard medical treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
standard-of-care imaging (18F-FDG, 68Ga-PSMA, or 68Ga-DOTATATE PET/CT), 68Ga-MY6349 PET/CT
The First People's Hospital of Lianyungang
Tumor
1 trial -
standard-of-care imaging (PSMA/FDG PET/CT), ACP3 PET/CT
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer (Diagnosis)
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources